Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyocera
Kyoto, Kyoto, Japanglobal.kyocera.com ↗
- Ownership
- Public · 6971
- Employees
- ~83001
- Development stage
- Other
01
Overview
Kyocera offers commercialized orthopedic joint replacements and dental implants using advanced ceramics/metals. Its SAW biosensor enables rapid point-of-care testing from urine/saliva samples. The company also provides cell separation/counting devices to support life sciences R&D. U.S. FDA clearance was obtained for artificial hip joints sold since at least 2017. No clinical trial data typical of drug development.
- Therapeutic areas
- RheumatologyOther
- Modalities
- DeviceImplantable deviceDiagnostic deviceCell separation technology/device
- Industry
- Implantable Medical Devices
02
Partnerships
Health Care Systems CorporationRenovis Surgical
03
Financials
- Market cap
- $22.5B
- Total revenue
- $13.1B
- Enterprise value
- $21.8B
Beyond the preview
Go deeper on Kyocera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kyocera.